References:
1. Wall, R. (2019) Flea and tick challenges - managing risk factors. Vet Times. 49(39). 2. Wright, I. (2012) Lyme disease: If you go down to the woods today are you in for a big surprise? Companion Animal. 17(6), 42-44. 3. Wright l, Stafford K, Coles G. The prevalence of intestinal nematodes in cats and dogs from Lancashire, north-west England. J Small Anim Pract 2016; 57: 393–395. 4. Ma G, Holland CV, Wang T, Hofmann A, Fan CK, Maizels RM, Hotez PJ, Gasser RB. Human toxocariasis. Lancet Infect. Dis. 2018; 18: e14–e24. 5. Quattrocchi G, Nicoletti A, Marin B, et al. Toxocariasis and epilepsy: systematic review and meta-analysis. PLoS Negl Trop Dis 2012;6:e1775. 6. Li L, Gao W, Yang X, et al. Asthma and toxocariasis. Ann Allergy Asthma Immunol 2014;113:187–192. 7. ESCCAP. Worm Control in Dogs and Cats. ESCCAP Guideline 01 Sixth Edition 2020.
NexGard® COMBO contains eprinomectin, esafoxolaner and praziquantel. UK: POM-V IE: POM. Advice should be sought from the prescriber. Further information available in the SPC or from Boehringer Ingelheim Animal Health UK Ltd., RG12 8YS, UK. Tel: 01344 746957. Email: vetenquiries@boehringer-ingelheim.com. NexGard® COMBO is a registered trademark of Boehringer Ingelheim Animal Health France SCS, used under licence. ©2023 Boehringer Ingelheim Animal Health UK Ltd. All rights reserved. Date of preparation: March 2023. UI-FEL-0017-2023. Use Medicines Responsibly.